BMY

Bristol-Myers Squibb
D

BMY

Arincen68/100B

Bristol-Myers Squibb P/E ratio

Bristol-Myers Squibb's P/E ratio is 14.03: its share price of 63.43 over its earnings per share of 4.52 over the last twelve months.

Today
14.03
Forward P/E, next 12 months
9.51
PEG ratio
1.90
Average, 5 years
18.77
Low, 5 years
12.09
High, 5 years
27.87

P/E ratio = price ÷ EPS (last 12 months) = 63.43 ÷ 4.52 = 14.03

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

P/E ratio by year and by quarter

Fiscal yearPeriod endingP/E ratioForward P/EMarket capNet income
FY2027 · Estimate31 Dec 20279.47———
FY2026 · Estimate31 Dec 20269.84———
Today14.039.51129.65B9.24B
FY202531 Dec 202515.608.37110.09B7.06B
FY202431 Dec 2024—9.26114.65B-8.93B
FY202331 Dec 202313.209.74106.16B8.04B
FY202231 Dec 202224.159.74153.25B6.35B
FY202131 Dec 202119.748.44138.48B7.01B
FY202031 Dec 2020—8.30140.06B-9.00B
FY201931 Dec 201931.6310.02109.44B3.46B
FY201831 Dec 201817.1611.1784.88B4.95B
FY201731 Dec 2017103.3915.85100.81B975.00M
FY201631 Dec 201621.6719.4897.65B4.51B
FY201531 Dec 201570.3124.08114.67B1.63B
FY201431 Dec 201448.2130.9697.81B2.03B
FY201331 Dec 201333.8734.2987.38B2.58B
FY201231 Dec 201221.7620.1254.43B2.50B
FY201131 Dec 201111.3918.3559.91B5.26B
FY201031 Dec 201010.0512.3745.36B4.51B
FY200931 Dec 20094.2013.0249.84B11.86B
FY200831 Dec 20087.3613.7645.97B6.24B
FY200731 Dec 200724.1317.5652.24B2.17B
FY200631 Dec 200632.5521.4351.59B1.59B
FY200531 Dec 200514.9524.9644.86B3.00B
FY200431 Dec 200420.8421.5349.75B2.39B
FY200331 Dec 200317.8422.0055.40B3.11B
FY200231 Dec 200221.6416.0846.24B2.14B
FY200131 Dec 200120.4735.4298.94B4.83B
FY200031 Dec 200029.3632.03138.34B4.71B
FY199931 Dec 199929.1029.46121.26B4.17B
FY199831 Dec 199840.3034.68126.59B3.14B
FY199731 Dec 199728.0028.0189.74B3.21B
FY199631 Dec 199618.2818.1852.11B2.85B
FY199531 Dec 199522.83—41.37B1.81B
FY199431 Dec 199415.23—28.06B1.84B
FY199331 Dec 199314.60—28.60B1.96B
FY199231 Dec 199220.49—32.84B1.60B
FY199131 Dec 199121.22—43.63B2.06B
FY199031 Dec 199018.99—33.19B1.75B
FY198931 Dec 198937.03—27.66B747.00M
FY198831 Dec 198817.95—22.51B1.25B
FY198731 Dec 198719.82—21.17B1.07B

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Bristol-Myers Squibb's P/E ratio

Source: Financial Modeling PrepVerified against SEC filings